Aurinia Pharmaceuticals (TSXV:AUP) CEO: Dr. Richard Glickman

 

Aurinia Pharmaceuticals
(TSXV:AUP)
Exectutive Chairman and Acting CEO: Dr. Richard Glickman

 

Expired

About The Wall Street Analyzer 1612 Articles
The Wall Street Analyzer's staff of writers, analysts, publishers, producers, market researchers, and PR professionals aim to provide investors with the tools they need to make informed decisions on buying stock. Our staff is a mix of financial professionals and media savvy individuals whose experiences bring the best talent from both ends of the spectrum.